Foundayo is indicated for use alongside a reduced-calorie diet and increased physical activity
Existing treatment options for the condition include several FDA-approved medications, along with a range of behavioral therapies and support programs, though researchers and clinicians have continued searching for additional treatment approaches given that no single existing option works effectively for every patient
The development process involved: Analysing the structure of human GLP-1 Making specific amino acid modifications to increase half-life Adding a fatty acid side chain to allow binding to albumin in the blood Testing for efficacy and safety through rigorous clinical trials This represents a common pattern in pharmaceutical development, where natural compounds inspire synthetic medicines that are more practical for therapeutic use
Furthermore, its weight loss effect, achieved by reducing fat accumulation, preserves an appropriate amount of muscle mass during weight reduction, preventing muscle atrophy due to nutritional deficiencies and maintaining normal physiological functions and bodily resistance
The third receptor target unique to Retatrutide among current obesity compounds
Wegovy - licensed for weight management) Dulaglutide (Trulicity - for type 2 diabetes) Liraglutide (Victoza - for type 2 diabetes